Clinical Impact of Recipient-Derived Isoagglutinin Levels in ABO-Incompatible Hematopoietic Stem Cell Transplantation

ABO incompatibility is not considered a contraindication for hematopoietic stem cell transplantation (HSCT). We hypothesized that recipient-derived isoagglutinin (RDI) levels could play a critical role in clinical outcomes. In this study, we compared clinical outcomes such as survival, GVHD, infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Minjeong, Hur, Mina, Kim, Hanah, Lee, Tae-Hwan, Lee, Gun-Hyuk, Yoon, Sumi, Park, Seungman, Kim, Sung Yong, Lee, Mark Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866227/
https://www.ncbi.nlm.nih.gov/pubmed/36675387
http://dx.doi.org/10.3390/jcm12020458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866227/
https://www.ncbi.nlm.nih.gov/pubmed/36675387
http://dx.doi.org/10.3390/jcm12020458

Ejemplares similares